184 related articles for article (PubMed ID: 24903990)
1. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.
Pang JY; Zhao KJ; Wang JB; Ma ZJ; Xiao XH
J Zhejiang Univ Sci B; 2014 Jun; 15(6):533-9. PubMed ID: 24903990
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Wang ZY; Li YQ; Guo ZW; Zhou XH; Lu MD; Xue TC; Gao B
Acta Pharmacol Sin; 2020 Feb; 41(2):278-285. PubMed ID: 31554961
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication.
Karamese M; Aydogdu S; Karamese SA; Altoparlak U; Gundogdu C
Asian Pac J Cancer Prev; 2015; 16(10):4199-202. PubMed ID: 26028072
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
7. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
Xu J; Wang J; Deng F; Hu Z; Wang H
Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the replication of hepatitis B virus in vitro by pu-erh tea extracts.
Pei S; Zhang Y; Xu H; Chen X; Chen S
J Agric Food Chem; 2011 Sep; 59(18):9927-34. PubMed ID: 21870867
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication.
Zhong L; Hu J; Shu W; Gao B; Xiong S
Cell Death Dis; 2015 May; 6(5):e1770. PubMed ID: 25996297
[TBL] [Abstract][Full Text] [Related]
10. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.
Xu J; Gu W; Li C; Li X; Xing G; Li Y; Song Y; Zheng W
J Nat Med; 2016 Jul; 70(3):584-91. PubMed ID: 26968537
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
He XX; Chen T; Lin JS; Chang Y; Ye BX
Biochem Biophys Res Commun; 2008 May; 369(2):513-8. PubMed ID: 18284916
[TBL] [Abstract][Full Text] [Related]
14. In vitro antiviral activity of lutein against hepatitis B virus.
Pang R; Tao JY; Zhang SL; Zhao L; Yue X; Wang YF; Ye P; Dong JH; Zhu Y; Wu JG
Phytother Res; 2010 Nov; 24(11):1627-30. PubMed ID: 21031619
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.
Ruan J; Sun S; Cheng X; Han P; Zhang Y; Sun D
Virol J; 2020 Jul; 17(1):89. PubMed ID: 32611423
[TBL] [Abstract][Full Text] [Related]
17. Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam.
Huang Q; Zhang S; Huang R; Wei L; Chen Y; Lv S; Liang C; Tan S; Liang S; Zhuo L; Lin X
J Ethnopharmacol; 2013 Nov; 150(2):568-75. PubMed ID: 24051027
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.
Hu Z; Hu J; Ren F; Xu H; Tan M; Wang Q; Ren J
Biochem Biophys Res Commun; 2020 Mar; 523(3):802-808. PubMed ID: 31954513
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
